DexCom, Inc.

Total Valuation

DexCom, Inc. carries a market capitalization of 33.17B, placing it among publicly traded companies globally. Its enterprise value stands at 24.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

DexCom, Inc. currently has 377.40M shares outstanding.

Valuation Ratios

DexCom, Inc. trades at a trailing price-to-earnings ratio of 26.02. The price-to-sales ratio is 5.24, and the price-to-book ratio stands at 9.70.

Enterprise Valuation

On an enterprise value basis, DexCom, Inc. trades at an EV/EBITDA multiple of 17.72 and an EV/FCF ratio of 11.82. The EV/Sales ratio of 5.00 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.83 provides insight into valuation relative to core operating earnings.

Financial Position

DexCom, Inc. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.35, indicating elevated leverage, while an interest coverage ratio of 93.55 demonstrates strong ability to service its debt obligations.

Financial Efficiency

DexCom, Inc. posts a return on equity of 38.49 and a return on invested capital of 19.21.

Taxes

Over the trailing twelve months, DexCom, Inc. has paid 280.30M in income taxes, reflecting an effective tax rate of 21.90.

Stock Price Statistics

DexCom, Inc.'s stock has gained approximately 12.69231% over the past 52 weeks. The 50-day moving average sits at 81.22, while the 200-day moving average is 70.90.

Income Statement

Over the trailing twelve months, DexCom, Inc. generated 4.97B in revenue and converted that into 999.70M in net income, yielding earnings per share of 2.51. EBITDA reached 1.40B, while operating income came in at 1.14B.

Balance Sheet

DexCom, Inc. holds 1.95B in cash and equivalents against 1.40B in total debt, resulting in a net debt position of 137.80M. Total book value stands at 2.62B, with working capital of 1.73B providing operational flexibility.

Cash Flow

DexCom, Inc. produced 1.75B in operating cash flow over the past twelve months. After subtracting -343.70M in capital expenditures, free cash flow totaled 1.41B - equivalent to 3.64 per share.

Margins

DexCom, Inc. operates with a gross margin of 62.47, reflecting its pricing power and cost economics. The operating margin of 22.92 and net profit margin of 20.12 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

DexCom, Inc.'s most recent stock split took place on June 13, 2022 with a 1:4 split ratio.

Scores

DexCom, Inc. posts an Altman Z-Score of 6.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.